Skip to main content

Persistent Asset Partners Ltd

Position in VKTX — Viking Therapeutics, Inc.

CIK 2056052 HONG KONG, K3

Position in VKTX

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$4,397,831
+$67,864 QoQ
Shares Held
112,736
-15.3% QoQ
Ownership
0.097%
of shares outstanding
% of Portfolio
1.46%
of 13F equity value
Holder Rank
#76
of 434 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VKTX Over Time

Shares Held

Position Value (USD)

Derivatives in VKTX

reported options exposure · as of Jun 30, 2026
CallValue
$121,120
CallShares
3,105
PutValue
$34,874
PutShares
894

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Persistent Asset Partners Ltd holds $74,585,923 across 142 Biotechnology names. VKTX ranks #5 (5.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 VKTX
Viking Therapeutics, Inc.
This page
112,736 $4,397,831

All Filings in VKTX

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,397,831 112,736
2026-06-30 $34,874 894
2026-06-30 $121,120 3,105
2026-03-31 $4,329,967 133,066
2026-03-31 $54,404 1,672
2025-12-31 $3,184,282 90,514
2025-09-30 $1,171,509 44,578
2025-06-30 $1,205,273 45,482
2025-03-31 $578,875 23,970